Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive - Monica B. Kirby; Brian M. Petersen; Jonathan G. Faris; Siobhan P. Kells; Kayla G. Sprenger; Timothy A. Whitehead (Proceedings of the National Academy of Sciences, 2025)